These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29483288)

  • 1. Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.
    Gomes RS; Silva MVT; Dos Santos JC; van Linge C; Reis JM; Teixeira MM; Pinto SA; Dorta ML; Bai X; Chan ED; Dinarello CA; Oliveira MAP; Joosten LAB; Ribeiro-Dias F
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29483288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immune response mediated by neutrophils in experimental visceral leishmaniasis is enhanced by IL-32γ.
    Gomes RS; Silva MVT; Oliveira MAP; Joosten LAB; Ribeiro-Dias F
    Cell Immunol; 2022 Jan; 371():104449. PubMed ID: 34784560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IL-32 in Bacillus Calmette-Guérin (BCG)-induced trained immunity in infections caused by different Leishmania spp.
    Silva MVT; Dos Santos JC; Figueiredo AMB; Teufel LU; Pereira JX; Matos GG; Pinto SA; Netea MG; Gomes RS; Joosten LAB; Ribeiro-Dias F
    Microb Pathog; 2021 Sep; 158():105088. PubMed ID: 34260904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.
    Nascimento MS; Carregaro V; Lima-Júnior DS; Costa DL; Ryffel B; Duthie MS; de Jesus A; de Almeida RP; da Silva JS
    J Infect Dis; 2015 Mar; 211(6):1015-26. PubMed ID: 25274569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response.
    Quirino GFS; Nascimento MSL; Davoli-Ferreira M; Sacramento LA; Lima MHF; Almeida RP; Carregaro V; Silva JS
    Infect Immun; 2016 Aug; 84(8):2289-2298. PubMed ID: 27245409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum.
    Figueiredo WME; Viana SM; Alves DT; Guerra PV; Coêlho ZCB; Barbosa HS; Teixeira MJ
    Mem Inst Oswaldo Cruz; 2017 Aug; 112(8):561-568. PubMed ID: 28767981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
    Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
    Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
    Dias DS; Ribeiro PAF; Martins VT; Lage DP; Ramos FF; Dias ALT; Rodrigues MR; Portela ÁSB; Costa LE; Caligiorne RB; Steiner BT; Chávez-Fumagalli MA; Salles BCS; Santos TTO; Silveira JAG; Magalhães-Soares DF; Roatt BM; Machado-de-Ávila RA; Duarte MC; Menezes-Souza D; Silva ES; Galdino AS; Coelho EAF
    Cell Immunol; 2018 Jan; 323():59-69. PubMed ID: 29128045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
    Ribeiro PAF; Dias DS; Lage DP; Martins VT; Costa LE; Santos TTO; Ramos FF; Tavares GSV; Mendonça DVC; Ludolf F; Gomes DA; Rodrigues MA; Chávez-Fumagalli MA; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
    Mol Immunol; 2019 Feb; 106():108-118. PubMed ID: 30594673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of visceral leishmaniasis due to Leishmania infantum in BALB/c mice is markedly slowed by prior infection with Trichinella spiralis.
    Rousseau D; Le Fichoux Y; Stien X; Suffia I; Ferrua B; Kubar J
    Infect Immun; 1997 Dec; 65(12):4978-83. PubMed ID: 9393785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
    de Jesus Pereira NC; Régis WC; Costa LE; de Oliveira JS; da Silva AG; Martins VT; Duarte MC; de Souza JR; Lage PS; Schneider MS; Melo MN; Soto M; Soares SA; Tavares CA; Chávez-Fumagalli MA; Coelho EA
    Exp Parasitol; 2015 Jun; 153():180-90. PubMed ID: 25845753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
    Duarte MC; Lage LM; Lage DP; Martins VT; Carvalho AM; Roatt BM; Menezes-Souza D; Tavares CA; Alves RJ; Barichello JM; Coelho EA
    Parasitol Int; 2016 Dec; 65(6 Pt A):728-736. PubMed ID: 27425599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of TGF-beta in murine visceral leishmaniasis.
    Wilson ME; Young BM; Davidson BL; Mente KA; McGowan SE
    J Immunol; 1998 Dec; 161(11):6148-55. PubMed ID: 9834100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
    Agallou M; Margaroni M; Karagouni E
    Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype.
    Resende M; Moreira D; Augusto J; Cunha J; Neves B; Cruz MT; Estaquier J; Cordeiro-da-Silva A; Silvestre R
    J Immunol; 2013 Jul; 191(1):262-73. PubMed ID: 23729437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.